Document is current
Any future updates will be listed below
-
Authors
Lorizio, Daniela
Silginer, Manuela
Friesen, Julia
Epstein, Alan L.
Weller, Michael
Roth, Patrick
-
Funding
Funding for this research was provided by:
Eurostars (OpSiS #765)
Universität Zürich (CRPP ImmunoCure)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF 310030_212358)
University of Zurich
- License Information
-
More Information
Article History
Received: 13 March 2025
Accepted: 26 May 2025
First Online: 28 June 2025
Declarations
:
: MW has received research grants from Novartis, Quercis and Versameb, and honoraria for lectures or advisory board participation or consulting from Anheart, Bayer, Curevac, Medac, Neurosense, Novartis, Novocure, Orbus, Pfizer, Philogen, Roche, and Servier. PR has received honoraria for lectures or advisory board participation from Alexion, Bristol-Myers Squibb, Boehringer Ingelheim, CDR-Life, Debiopharm, Galapagos, Laminar, Midatech Pharma, Novartis, Novocure, OM Pharma, QED, Roche, Sanofi, and Servier and research support from Merck Sharp and Dohme and TME Pharma. DL, MS, JF, and AE have nothing to disclose.
: All animal experiments were authorized by the Veterinary Office of the Canton of Zurich.
